Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, representing a minor, internal update to the ClinicalTrials.gov page rather than a modification to study data or visible content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s footer “Revision” version was increased from v3.5.2 to v3.5.3, indicating a backend/software release update without changing the study information presented.SummaryDifference0.1%

- Check34 days agoChange DetectedAddition: Revision v3.5.2; Deletion: Revision v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe site footer revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedThe site revision displayed changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedSite update to revision v3.4.2; the funding/operating status notice has been removed and there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.